Georgia Bio and Brex Partner to Enhance Member Benefits
Exciting news for Georgia Bio members! The Georgia Bio Brex program, established through our partnership with BIO, has been expanded to provide even greater benefits for your organization. On top of the existing corporate credit card with its industry-specific rewards, members can now access savings on business accounts, spend management software, and travel management solutions.
Upgrade Your Financial Toolkit Learn more and upgrade at bio.org/save/brex
Enhanced Benefits at a Glance
- High-Yield Business Accounts: Enjoy industry-leading yields, effortless wire transfers, and global ACH capabilities with your Brex business account. Brex partner banks offer a competitive 4.92% APY with same-day liquidity, all FDIC-insured up to $6 million. Additionally, you can make free bill payments, international ACH transfers, issue checks, and send wires. Brex accounts can even accommodate up to 240 unique account numbers.
- Scalable Spend Management:
Brex’s advanced spend management system empowers you to manage your company’s spending and close the books in real-time. Features include:
- Budgets with automated enforcement of spending policies
- Streamlined employee reimbursements with advanced approval workflows
- Customizable approval processes to automate in-policy spending approvals
- Global reimbursements in local currencies and accounts
- Automatic receipt generation, eliminating the need for manual receipt collection and expense reports
- Integration with thousands of tools to streamline workflows
- Comprehensive Travel & Expense Management:
Simplify travel and group event management with a unified solution encompassing travel booking, event coordination, expense tracking, corporate cards, and reimbursements. Brex’s travel and expense features include:
- Consolidated booking for flights, hotels, and car rentals
- Integrated travel policy enforcement
- Access to a vast, unbiased global travel inventory
- Pre-negotiated discounts
- Tools to achieve 100% travel program adoption within your organization
Georgia Bio’s commitment to empowering its members is stronger than ever. With the enhanced Brex program, you can streamline financial processes, gain real-time insights into spending, and optimize travel management, all while earning industry-leading returns on your business accounts.
January 20, 2026. Paulding County has been designated a BioReady Silver Community by Georgia Life Sciences, the state’s leading life sciences membership organization. The BioReady designation recognizes communities that demonstrate strong zoning practices, infrastructure capacity, and readiness to support biotechnology and life sciences development. “We are proud to recognize Paulding County as our newest BioReady Silver community,” said Maria Thacker-Goethe, President and CEO of Georgia Life Sciences. “Paulding County’s proactive planning, growing workforce, and access to regional healthcare and transportation infrastructure position it well to support life sciences manufacturing and commercialization. Through the BioReady program, we champion communities that are intentionally preparing to compete for industry investment and job growth.” Paulding County’s designation reflects its commitment to thoughtful land-use planning, scalable infrastructure, and business-friendly development policies that support life sciences and advanced manufacturing uses. Located in the northwest Atlanta metro region, the county offers access to a strong labor pool, major transportation corridors, and regional healthcare systems, making it an attractive option for biotechnology, medical device, diagnostics, and related life sciences companies seeking room to grow. “Georgia BioReady designation validates Paulding County’s readiness to support bioscience investment and strengthens our position as a growing hub for advanced industries,” said Alex Almodovar, President & CEO, Paulding County Economic Development Inc. & Industrial Building Authority The BioReady rating system evaluates communities across three tiers—Bronze, Silver, and Gold—based on their readiness to attract and support life sciences facilities. Through these ratings, Georgia Life Sciences helps municipalities better showcase biotech-appropriate sites, strengthen infrastructure planning, and clearly identify life sciences-friendly locations. This approach enables communities like Paulding County to compete more effectively for private investment and high-quality job creation. Georgia Life Sciences advances innovation, strengthens the workforce pipeline, and grows Georgia’s life sciences economy through the BioReady Community program, modeled after MassBio’s nationally recognized rating system, which assesses a community’s readiness to host life sciences facilities based on zoning practices and infrastructure capacity. About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
What happens when students see real work before choosing a future
By: Patrick Plues | RealClearHealth January 8, 2026 For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments. But other countries, including China, are sparing no expense in the bid to overtake us. Beijing has officially made biotechnology a national strategic priority and is pouring billions into state-backed research and manufacturing efforts. All states should consider impactful biotech policies that grow and strengthen our domestic biotechnology industry. If states fail to utilize and replicate what are considered to be the best and most successful policies in biotech-focused economic development, the United States will soon lose its long-term leadership in developing medicines and medical technologies, which underpin our health, our economy, and our national security. Thankfully, many governors and state legislatures around the country are already answering this call -- as our new study, The U.S. Bioscience Industry: A Powerful Engine for State Economies, demonstrates. Keep Reading at https://www.realclearhealth.com/2026/01/08/americas_biotech_leadership_depends_on_the_states_1157584.html
